{
    "Variants Include": [
        {
            "Gene": "PINK1",
            "variants": [
                {
                    "HGVS": "NM_032409.3:c.1310C>T",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "1310"
                    },
                    "Protein Change": {
                        "ref": "W",
                        "alt": "X",
                        "position": "437"
                    },
                    "Description in input context": "W437X"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005586"
    },
    "Experiment Method": [
        {
            "Assay Method": "Mitochondrial Respiratory Function Assay",
            "Material used": {
                "Material Source": "Patient-derived fibroblasts",
                "Material Name": "Fibroblasts from a patient with PINK1 mutation",
                "Description": "Mitochondrial respiratory function of fibroblasts from a patient affected by early-onset Parkinsonism carrying the homozygous W437X nonsense mutation in the PINK1 gene has been thoroughly characterized."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.1310C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Decreased respiratory activity and a decreased respiratory control ratio",
                    "Result Description": "The patient’s fibroblast mitochondria exhibited a lower respiratory activity and a decreased respiratory control ratio with cellular ATP supply relying mainly on enhanced glycolytic production."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "The values shown are mean ± SEM of 5–7 assays with different cell preparations."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Two tailed Student’s t-test"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Oxidative Phosphorylation Complexes Assay",
            "Material used": {
                "Material Source": "Patient-derived fibroblasts",
                "Material Name": "Fibroblasts from a patient with PINK1 mutation",
                "Description": "The quantity, specific activity and subunit pattern of the oxidative phosphorylation complexes were normal."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.1310C>T",
                    "Conclusion": "Normal",
                    "Molecular Effect": "Normal quantity, specific activity and subunit pattern",
                    "Result Description": "The quantity, specific activity and subunit pattern of the oxidative phosphorylation complexes were normal."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cytochrome c Content Assay",
            "Material used": {
                "Material Source": "Patient-derived fibroblasts",
                "Material Name": "Fibroblasts from a patient with PINK1 mutation",
                "Description": "A significant decrease of the cellular cytochrome c content was observed."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.1310C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Decreased cytochrome c content",
                    "Result Description": "A significant decrease of the cellular cytochrome c content was observed and this correlated with a reduced cytochrome c oxidase in situ activity."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Reactive Oxygen Species (ROS) Assay",
            "Material used": {
                "Material Source": "Patient-derived fibroblasts",
                "Material Name": "Fibroblasts from a patient with PINK1 mutation",
                "Description": "Measurement of ROS revealed in mitochondria of the patient’s fibroblasts enhanced O2 •- and H2O2 production abrogated by inhibition of complex I."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.1310C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Enhanced O2 •- and H2O2 production",
                    "Result Description": "Measurement of ROS revealed in mitochondria of the patient’s fibroblasts enhanced O2 •- and H2O2 production abrogated by inhibition of complex I."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}